Cargando…
Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393809/ https://www.ncbi.nlm.nih.gov/pubmed/34445967 http://dx.doi.org/10.1186/s10194-021-01307-6 |
| _version_ | 1783743809699446784 |
|---|---|
| author | Ament, Michael Day, Kathleen Stauffer, Virginia L. Skljarevski, Vladimir Rettiganti, Mallikarjuna Pearlman, Eric Aurora, Sheena K. |
| author_facet | Ament, Michael Day, Kathleen Stauffer, Virginia L. Skljarevski, Vladimir Rettiganti, Mallikarjuna Pearlman, Eric Aurora, Sheena K. |
| author_sort | Ament, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8393809 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Milan |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83938092021-08-30 Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine Ament, Michael Day, Kathleen Stauffer, Virginia L. Skljarevski, Vladimir Rettiganti, Mallikarjuna Pearlman, Eric Aurora, Sheena K. J Headache Pain Correction Springer Milan 2021-08-26 /pmc/articles/PMC8393809/ /pubmed/34445967 http://dx.doi.org/10.1186/s10194-021-01307-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Ament, Michael Day, Kathleen Stauffer, Virginia L. Skljarevski, Vladimir Rettiganti, Mallikarjuna Pearlman, Eric Aurora, Sheena K. Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine |
| title | Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine |
| title_full | Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine |
| title_fullStr | Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine |
| title_full_unstemmed | Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine |
| title_short | Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine |
| title_sort | correction to: effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393809/ https://www.ncbi.nlm.nih.gov/pubmed/34445967 http://dx.doi.org/10.1186/s10194-021-01307-6 |
| work_keys_str_mv | AT amentmichael correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine AT daykathleen correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine AT stauffervirginial correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine AT skljarevskivladimir correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine AT rettigantimallikarjuna correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine AT pearlmaneric correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine AT aurorasheenak correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine |